Bioimpedance Spectroscopy for Breast Cancer-Related Lymphedema

Richard Carreon, Managing Director & Chief Executive Officer at ImpediMed discusses SOZO®, bioimpedance spectroscopy that enables healthcare professionals to non-invasively measure, monitor and better manage lymphedema, particularly in breast cancer surgery patients at a much earlier point.

Richard Carreon was appointed to the Board as Executive Director in May 2015. Rick joined ImpediMed in July 2012 as President and Chief Executive Officer. Rick has more than 30 years of experience in management, sales and marketing, spanning the consumer products and medical technology industries. Rick has more than a decade of executive experience working for Medtronic, a leading global manufacturer of cutting-edge medical devices, and therapies. His roles at Medtronic included Vice President, US Cardiovascular Commercial Operations; Vice President of Sales – Structural Heart; Vice President of Sales and Marketing Medtronic Gastroenterology and Urology; and Vice President of Sales – The Americas. At Medtronic, Rick led the strategic direction and tactical planning for several sales organizations within Medtronic’s $1.1B Cardiovascular Sector. Rick was handpicked to lead the start-up of Medtronic Gastroenterology and Urology, a high-risk business venture, growing revenues threefold, and building that venture into the fastest growing business in Medtronic. Rick has a strong sales background, extensive marketing strategy and execution experience, and a proven track record of success